NCT03955445 - Long-term Efficacy, Safety and Tolerability of Iptacopan in C3G or IC-MPGN | Biotech Hunter

Enrollment

225

Participants

Timeline

Start Date

October 3, 2019

Primary Completion Date

May 30, 2036

Study Completion Date

May 30, 2036

Conditions

C3 GlomerulopathyImmune-complex-membranoproliferative Glomerulonephritis

Interventions

DRUG

LNP023

LNP023 capsules

Trial Locations (43)

2333

RECRUITING

Novartis Investigative Site, Leiden

3010

RECRUITING

Novartis Investigative Site, Bern

10032

RECRUITING

Col Uni Med Center New York Presby, New York

20246

RECRUITING

Novartis Investigative Site, Hamburg

24020

RECRUITING

Novartis Investigative Site, Ranica

28040

RECRUITING

Novartis Investigative Site, Madrid

28041

RECRUITING

Novartis Investigative Site, Madrid

30046

RECRUITING

Georgia Nephrology Research Inst, Lawrenceville

31008

RECRUITING

Novartis Investigative Site, Pamplona

31054

RECRUITING

Novartis Investigative Site, Toulouse

34295

RECRUITING

Novartis Investigative Site, Montpellier

38039

RECRUITING

Novartis Investigative Site, Talas Kayseri

41009

RECRUITING

Novartis Investigative Site, Seville

41380

RECRUITING

Novartis Investigative Site, Kocaeli

45147

RECRUITING

Novartis Investigative Site, Essen

55131

RECRUITING

Novartis Investigative Site, Mainz

71110

RECRUITING

Novartis Investigative Site, Heraklion Crete

75015

RECRUITING

Novartis Investigative Site, Paris

80045

RECRUITING

Childrens Hospital Colorado, Aurora

91054

ACTIVE_NOT_RECRUITING

Novartis Investigative Site, Erlangen

100034

RECRUITING

Novartis Investigative Site, Beijing

200040

RECRUITING

Novartis Investigative Site, Shanghai

4920235

RECRUITING

Novartis Investigative Site, Petah Tikva

4941492

RECRUITING

Novartis Investigative Site, Petah Tikva

52242-1091

RECRUITING

University of Iowa Health Care, Iowa City

W3400ABH

RECRUITING

Novartis Investigative Site, Buenos Aires

30150-221

RECRUITING

Novartis Investigative Site, Belo Horizonte

90035-074

RECRUITING

Novartis Investigative Site, Porto Alegre

3880-1001

RECRUITING

Novartis Investigative Site, Botucatu

04038-002

RECRUITING

Novartis Investigative Site, São Paulo

M5G 2C4

ACTIVE_NOT_RECRUITING

Novartis Investigative Site, Toronto

128 08

ACTIVE_NOT_RECRUITING

Novartis Investigative Site, Prague

00165

RECRUITING

Novartis Investigative Site, Roma

466 8560

ACTIVE_NOT_RECRUITING

Novartis Investigative Site, Nagoya

078 8510

ACTIVE_NOT_RECRUITING

Novartis Investigative Site, Asahikawa

060-8543

COMPLETED

Novartis Investigative Site, Sapporo

569 1192

ACTIVE_NOT_RECRUITING

Novartis Investigative Site, Takatsuki

520-2192

RECRUITING

Novartis Investigative Site, Ohtsu

951 8520

ACTIVE_NOT_RECRUITING

Novartis Investigative Site, Niigata

08035

ACTIVE_NOT_RECRUITING

Novartis Investigative Site, Barcelona

06500

RECRUITING

Novartis Investigative Site, Ankara

W12 0HS

RECRUITING

Novartis Investigative Site, London

NE7 7DN

RECRUITING

Novartis Investigative Site, Newcastle upon Tyne